AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90 | +650.0% | 1,966 | +859.0% | 0.07% | +655.6% |
| Q2 2023 | $12 | +500.0% | 205 | +355.6% | 0.01% | +350.0% |
| Q1 2023 | $2 | 0.0% | 45 | +18.4% | 0.00% | +100.0% |
| Q4 2022 | $2 | – | 38 | +192.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 13 | -50.0% | 0.00% | -100.0% |
| Q2 2022 | $1,000 | -85.7% | 26 | -87.1% | 0.00% | -80.0% |
| Q1 2022 | $7,000 | +40.0% | 201 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $5,000 | – | 201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 29,423 | $583,000 | 0.44% |
| Matarin Capital Management, LLC | 223,184 | $4,426,000 | 0.34% |
| Summit Global Investments | 42,725 | $847,000 | 0.10% |
| FEDERATED HERMES, INC. | 1,747,921 | $34,661,000 | 0.08% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 347,307 | $6,887,000 | 0.08% |
| MARSHALL WACE, LLP | 413,293 | $8,196,000 | 0.06% |
| BOSTON ADVISORS LLC | 42,365 | $840,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 177,321 | $3,516,000 | 0.04% |
| MARTINGALE ASSET MANAGEMENT L P | 214,444 | $4,254,000 | 0.04% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 231,041 | $4,582,000 | 0.04% |